Yuxing Hu

Guangzhou, 510280, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Administration of lipid nanoparticle-encapsulated mRNA encoding CCR7, CXCL16 and GITRL effectively mobilizes antitumor T cell immunity.

Administration of lipid nanoparticle-encapsulated mRNA encoding CCR7, CXCL16 and GITRL effectively mobilizes antitumor T cell immunity.

Journal: International journal of biological macromolecules

Published: December 22, 2024

Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias.

Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias.

Journal: Cell

Published: July 28, 2024

Overexpression of Pin1 regulated by TOP2A, which subsequently stabilizes Pyk2 to promote bortezomib resistance in multiple myeloma.

Overexpression of Pin1 regulated by TOP2A, which subsequently stabilizes Pyk2 to promote bortezomib resistance in multiple myeloma.

Journal: Cancer gene therapy

Published: April 14, 2024

Recent Advances in Material Technology for Leukemia Treatments.

Recent Advances in Material Technology for Leukemia Treatments.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: December 20, 2023

Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma.

Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma.

Journal: Cancer letters

Published: November 26, 2023

Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients.

Dendritic cell vaccines extend CAR T-cell persistence and improve the efficacy of CD19 CAR T-cell therapy in refractory or relapsed adult B-ALL patients.

Journal: American journal of hematology

Published: September 25, 2023

Corrigendum to "Tegaserod maleate exhibits antileukemic activity by targeting TRPM8" [Biomed. Pharmacother. 154 (2022) 113566].

Corrigendum to "Tegaserod maleate exhibits antileukemic activity by targeting TRPM8" [Biomed. Pharmacother. 154 (2022) 113566].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 27, 2023

Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment.

Enhanced tumor immunotherapy by polyfunctional CD19-CAR T cells engineered to secrete anti-CD47 single-chain variable fragment.

Journal: International journal of biological sciences

Published: May 30, 2023

Low doses of IFN-γ maintain self-renewal of leukemia stem cells in acute myeloid leukemia.

Low doses of IFN-γ maintain self-renewal of leukemia stem cells in acute myeloid leukemia.

Journal: Oncogene

Published: April 05, 2023

Abemaciclib drives the therapeutic differentiation of acute myeloid leukaemia stem cells.

Abemaciclib drives the therapeutic differentiation of acute myeloid leukaemia stem cells.

Journal: British journal of haematology

Published: December 06, 2022

Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia.

Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia.

Journal: Cell death & disease

Published: November 26, 2022

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice.

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice.

Journal: Blood

Published: October 11, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026